Vivus CEO Optimistic On FDA Approval for Qnexa
February 27, 2012 at 13:29 PM EST
Vivus CEO Leland Wilson saw "a very powerful signal" that anti-obesity drug Qnexa would be approved.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.